PEAR - Why Is Pear Therapeutics (PEAR) Stock Down 26% Today?
2023-04-14 09:03:04 ET
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Pear Therapeutics (NASDAQ: PEAR ) stock is falling on Friday after the company’s recent bankruptcy filing continues to weigh on its shares.
Pear Therapeutics announced its bankruptcy filing while markets were closed for Good Friday. As a result, the company’s stock underwent a major fall on Monday. Since then, its shares have been somewhat volatile with rises and falls throughout the week.
That continues on Friday with heavy trading sending shares of PEAR stock lower as investors sell their stakes. As of this writing, more than 14 million shares of the company’s stock have changed hands. That’s already well above the company’s daily average trading volume of 6.1 million shares.
What to Know About the Bankruptcy
Pear Therapeutics notes that its debtors are currently considering a sale of the business. That includes the possibility of selling the entire business to a buyer. If not, then the debtors will seek to sell assets from the business instead. That could result in multiple buyers acquiring parts of Pear Therapeutics.
Considering debtors’ plans for Pear Therapeutics, it makes sense that PEAR stock would be down. There doesn’t seem to be a future for shares of the company’s stock. At this rate, it’s likely PEAR will end up delisted.
PEAR stock is down 26.2% during pre-market trading on Friday!
Investors searching for more of the latest stock market news are in luck!
We’ve got all of the biggest stock stories worth reading about on Friday! A few examples include why shares of Petros Pharma (NASDAQ: PTPI ) and CXApp (NASDAQ: CXAI ) stock are up and more. You can find all of that news at the links below!
More Friday Stock Market News
- Why Is Petros Pharmaceuticals (PTPI) Stock Up 101% Today?
- Why Is CXApp (CXAI) Stock Up 213% Today?
- Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
On Penny Stocks and Low-Volume Stocks: With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that?InvestorPlace.com’s writers disclose this fact and warn readers of the risk.
Read More: Penny Stocks — How to Profit Without Getting Scammed
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines .
More From InvestorPlace
- Buy This $5 Stock BEFORE This Apple Project Goes Live
- The Best $1 Investment You Can Make Today
- It doesn’t matter if you have $500 or $5 million. Do this now.
- Massive Bear Market “Divergence Event” Ahead… And The #1 Way to Play It
The post Why Is Pear Therapeutics (PEAR) Stock Down 26% Today? appeared first on InvestorPlace .